In some countries, this medicine may only be approved for veterinary use.
In the US, Bromocriptine (bromocriptine systemic) is a member of the following drug classes: dopaminergic antiparkinsonism agents, prolactin inhibitors and is used to treat Acromegaly, Diabetes - Type 2, Hyperprolactinemia and Parkinson's Disease.
US matches:
- Bromocriptine
- Bromocriptine Mesylate
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
G02CB01,N04BC01
CAS registry number (Chemical Abstracts Service)
0025614-03-3
Chemical Formula
C32-H40-Br-N5-O5
Molecular Weight
654
Therapeutic Categories
Prolactin inhibitor
Treatment of Parkinson's disease: Dopaminergic
Chemical Name
Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'α)-
Foreign Names
- Bromocriptinum (Latin)
- Bromocriptin (German)
- Bromocriptine (French)
- Bromocriptina (Spanish)
Generic Names
- Bromocriptina (OS: DCIT)
- Bromocriptine (OS: BAN, USAN, DCF)
- CB-154 (IS: Novartis)
- Bromocriptine Mesilate (OS: JAN, BANM)
- Bromocriptine Mesylate (OS: USAN)
- Bromocriptine methanesulfonate (IS)
- CB 154 (IS: Sandoz)
- Bromocriptine (mésilate de) (PH: Ph. Eur. 6)
- Bromocriptine Mesilate (PH: BP 2010, JP XV, Ph. Eur. 6)
- Bromocriptine Mesylate (PH: USP 32)
- Bromocriptini mesilas (PH: Ph. Eur. 6)
- Bromocriptinmesilat (PH: Ph. Eur. 6)
Brand Names
- Aprolac
AC Farma, Peru - Aspen Bromocriptine
Aspen Pharmacare, South Africa - Brocriptin
Biofarm, Romania - Bromocriptina Generis
Generis, Portugal - Bromocriptina
Farmindustria, Peru; Iqfarma, Peru; Medicalex, Colombia - Bromocriptine
Teriak, Tunisia - Bromokriptin
Zdravlje, Serbia - Kriptonal
Chemopharma, Chile - Parlodel
Novartis, Turkey; Novartis Pharmaceuticals, Peru - Pravidel
Meda, Luxembourg - Ronalin
Hikma, United Arab Emirates; Hikma, Bahrain; Hikma, Egypt; Hikma, Iraq; Hikma, Jordan; Hikma, Kuwait; Hikma, Lebanon; Hikma, Libya; Hikma, Oman; Hikma, Qatar; Hikma, Saudi Arabia; Hikma, Sudan; Hikma, Syria; Hikma, Tunisia; Hikma, Yemen; IBN, Tunisia - Alpha Bromocriptine
Apotex, New Zealand - Apo-Bromocriptine
Apotex, Canada; Apotex, Hong Kong; Apotex, Singapore - Bomoting
Gedeon Richter, China - Brameston
Remedica, Kenya; Remedica, Sudan; Remedica, Zimbabwe - Bromergon
Lek, Croatia (Hrvatska); Lek, Poland; Lek, Slovenia; Novartis, Bangladesh - Bromocorn
Filofarm, Poland - Bromocriptin AbZ
AbZ, Germany - Bromocriptin beta
Betapharm, Germany - Bromocriptin Hexal
Hexal, Germany - Bromocriptin Richter
Gedeon Richter, Estonia; Gedeon Richter, Georgia; Gedeon Richter, Hong Kong; Gedeon Richter, Hungary; Gedeon Richter, Lithuania; Gedeon Richter, Latvia; Gedeon Richter, Russian Federation - Bromocriptina Dorom
Dorom, Italy; Poli, Romania - Bromocriptin-CT
CT Arzneimittel, Germany - Bromocriptine Mesylate
Lek, United States; Mylan, United States; Paddock, United States; Rosemont, United States; Sandoz, United States; Zydus, United States - Bromocriptine Poli
Poli, Lithuania - Bromocriptine Sopharma
Sopharma, Bulgaria - Bromocriptine
Gedeon Richter, Bangladesh; Gedeon Richter, Ethiopia - Bromocriptine-Richter
Gedeon Richter, Singapore - Bromocriptin-ratiopharm
Ratiopharm, Germany - Bromodel
Opsonin, Bangladesh - Bromo-Kin
Sanofi-Aventis, France - Bromtine
Duopharma, Bangladesh; Duopharma, Hong Kong - Corpadel
Kyowa Yakuhin, Japan - Cripsa
Caprifarmindo, Indonesia - Criptine
Renata, Bangladesh - Criten
Tecnofarma, Chile - Cycloset
VeroScience, United States - Deparo
Towa Yakuhin, Japan - Erenant
Sandoz, Japan - Grifocriptina
Chile, Chile - Gynodel
Il-Ko, Turkey - Kirim
Hormosan, Germany - Kripton
Alphapharm, Australia - Lactafal (veterinary use)
Eurovet, Netherlands - Medocriptine
Medochemie, Bangladesh; Medochemie, Czech Republic; Medochemie, Hong Kong; Medochemie, Sri Lanka; Medochemie, Slovakia - Melen
Tatsumi Kagaku, Japan - Padoparine
Kotobuki Seiyaku, Japan - Palolactin
Fuji Yakuhin, Japan - Parilac
Teva, Israel - Parlodel
Euro, Netherlands; Med Pharm, Italy; Meda, Austria; Meda, Denmark; Meda, Finland; Meda, France; Meda, France; Meda, United Kingdom; Meda, Ireland; Meda, Netherlands; Meda, Norway; Meda, Portugal; Meda Pharma Sau, Spain; Novartis, United Arab Emirates; Novartis, Argentina; Novartis, Australia; Novartis, Bangladesh; Novartis, Belgium; Novartis, Bahrain; Novartis, Brazil; Novartis, Switzerland; Novartis, Chile; Novartis, China; Novartis, Colombia; Novartis, Czech Republic; Novartis, Estonia; Novartis, Ethiopia; Novartis, Ghana; Novartis, Greece; Novartis, Hong Kong; Novartis, Indonesia; Novartis, Israel; Novartis, Iceland; Novartis, Jordan; Novartis, Japan; Novartis, Kenya; Novartis, Kuwait; Novartis, Lebanon; Novartis, Sri Lanka; Novartis, Libya; Novartis, Malaysia; Novartis, Nigeria; Novartis, Oman; Novartis, Philippines; Novartis, Poland; Novartis, Qatar; Novartis, Russian Federation; Novartis, Saudi Arabia; Novartis, Sudan; Novartis, Singapore; Novartis, Syria; Novartis, Thailand; Novartis, Taiwan; Novartis, Tanzania; Novartis, United States; Novartis, Venezuela; Novartis, Yemen; Novartis, South Africa; Novartis, Zimbabwe; Novartis Consumer Health, Egypt; Novartis Pharmaceuticals, Peru; Sandoz, Mexico - Parlodel (veterinary use)
Novartis Animal Health, United Kingdom - Parloder
Novartis, Slovakia - Parlomin
Daito, Japan - Parukizone
Medisa Shinyaku, Japan - PMS-Bromocriptine
Pharmascience, Canada - Pravidel
Meda, Germany; Meda, Sweden; Novartis, Luxembourg - Prigost
Rider, Chile - Prospeline
Sawai Seiyaku, Japan - Pseudogravin (veterinary use)
Alvetra u. Werfft, Austria - Sicriptin
Serum Institute, India - Umprel
Meda, Austria - Upnol B
Takata Seiyaku, Japan
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment